Advertisement

Current Diabetes Reports

, Volume 4, Issue 1, pp 20–25 | Cite as

The role of electron beam computed tomography for measuring coronary artery atherosclerosis

  • Theodore Mazzone
Article

Abstract

It is generally agreed that the coronary artery calcium score provides significant information for the prediction of future cardiac events. However, additional information is needed to determine whether or not this information is significantly greater than that available from the analysis of established risk factors. Until this is resolved, it is unlikely that electron beam computed tomography can be justified for routine evaluation of patients. However, measurement of coronary artery calcium may be valuable in selected clinical situations, and has potential as a research tool for studying the pathogenesis or treatment of stable coronary artery disease.

Keywords

Coronary Artery Calcium Coronary Artery Calcium Score Arterioscler Thromb Vasc Biol Cardiac Risk Factor Electron Beam Compute Tomography 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Wilson PWF, Kannel WB: Epidemiology of hyperglycemia and atherosclerosis. In Hyperglycemia, Diabetes, and Vascular Disease. Edited by Ruderman N, et al. New York: Oxford University Press; 1992:21–29.Google Scholar
  2. 2.
    Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patibdents who have had acute myocardial infarction. Ann Intern Med 1997, 126:296–306.PubMedGoogle Scholar
  3. 3.
    D'Agostino RB, Grundy S, Sullivan LM, et al.: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180–187.PubMedCrossRefGoogle Scholar
  4. 4.
    Canto JG, Iskandrian AE: Major risk factors for cardiovascular disease: debunking the "only 50%" myth. JAMA 2003, 290:947–949.PubMedCrossRefGoogle Scholar
  5. 5.
    Raggi P: Coronary calcium on electron beam tomography imaging as a surrogate marker of coronary artery disease. Am J Cardiol 2001, 87suppl):27A-34A.PubMedCrossRefGoogle Scholar
  6. 6.
    Bostrom K, Watson KE, Horn S, et al.: Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993, 91:1800–1809.PubMedCrossRefGoogle Scholar
  7. 7.
    Janowitz WR, Agatston AS, Kaplan G, et al.: Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993, 72:247–254.PubMedCrossRefGoogle Scholar
  8. 8.
    Newman AB, Naydeck BL, Whittle J: Racial differences in coronary artery calcification in older adults. Arterioscler Thromb Vasc Biol 2002, 22:424–430.PubMedCrossRefGoogle Scholar
  9. 9.
    Newman AB, Naydeck BL, Sutton-Tyrell K, et al.: Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation 2001, 104:2679–2684.PubMedGoogle Scholar
  10. 10.
    Colhoun HM, Otvos JD, Rubens MB, et al.: Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 2002, 51:1949–1956.PubMedCrossRefGoogle Scholar
  11. 11.
    Calhoun HM, Scheek LM, Rubens MB, et al.: Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 2001, 50:652–659.CrossRefGoogle Scholar
  12. 12.
    Goodman WG, Goldin J, Kuizon BD, et al.: Coronary artery calcification in young adults with end stage renal disease who are undergoing dialysis. N Engl J Med 2000, 342:1478–1483.PubMedCrossRefGoogle Scholar
  13. 13.
    Schurgin S, Rich S, Mazzone T: Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 2001, 24:335–338. Illustrates that the distribution of CACS is shifted to higher levels in patients with diabetes even after matching for coronary artery risk factors.PubMedCrossRefGoogle Scholar
  14. 14.
    Wagenknecht LE, Bowden DW, Carr JJ, et al.: Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 2001, 50:861–866.PubMedCrossRefGoogle Scholar
  15. 15.
    Hoff JA, Quinn L, Sevrukov A, et al.: The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol 2003, 41:1008–1012.PubMedCrossRefGoogle Scholar
  16. 16.
    Hosoi M, Sato T, Yamagami K, et al.: Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients. Diabetes Care 2002, 25:696–701.PubMedCrossRefGoogle Scholar
  17. 17.
    Olson JC, Edmundowicz D, Becker DJ, et al.: Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes 2000, 49:1571–1578. Establishes a significant relationship between elevated coronary artery calcium and clinical evidence of CAD in patients with type 1 diabetes.PubMedCrossRefGoogle Scholar
  18. 18.
    Qu W, Le TT, Azen SP, et al.: Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care 2003, 26:905–910.PubMedCrossRefGoogle Scholar
  19. 19.
    Wong ND, Sciammarella MG, Polk D, et al.: The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003, 41:1547–1553.PubMedCrossRefGoogle Scholar
  20. 20.
    Arad Y, Newstein D, Cader F, et al.: Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 2001, 21:2051–2058.PubMedGoogle Scholar
  21. 21.
    Falk E, Shah P, Fuster V: Coronary plaque disruption. Circulation 1995, 92:656–671.Google Scholar
  22. 22.
    Davies MJ: The pathophysiology of acute coronary syndromes. Heart 2000, 83:361–366.PubMedCrossRefGoogle Scholar
  23. 23.
    He Z-X, Hedrick TD, Pratt CM, et al.: Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation 2000, 101:244–251.PubMedGoogle Scholar
  24. 24.
    Keelan PC, Bielak LF, Ashai K, et al.: Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 2001, 104:412–417.PubMedGoogle Scholar
  25. 25.
    Raggi P, Callister TQ, Cooil B, et al.: Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000, 101:850–855.PubMedGoogle Scholar
  26. 26.
    Arad Y, Spadar LA, Goodman K, et al.: Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000, 36:1253–1260.PubMedCrossRefGoogle Scholar
  27. 27.
    Detrano RC, Wong ND, Doherty TM, et al.: Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999, 99:2633–2638.PubMedGoogle Scholar
  28. 28.
    Kondos GT, Hoff JA, Seyrukov A, et al.: Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 2003, 107:2571–2576. Examined a large number of patients and demonstrated that an elevated CACS provided significant incremental information, over that provided by conventional CAD risk factor assessment, for predicting future cardiac events.PubMedCrossRefGoogle Scholar
  29. 29.
    O'Rourke RA, Brundage BH, Froelicher VF, et al.: American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000, 102:126–140.PubMedGoogle Scholar
  30. 30.
    Greenland P, Gaziano M: Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 2003, 349:465–473.PubMedCrossRefGoogle Scholar
  31. 31.
    Greenland P, Smith SC, Grundy SM: Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001, 104:1863–1867.PubMedGoogle Scholar
  32. 32.
    Callister TQ, Raggi P, Cooil B: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998, 339:1972–1978.PubMedCrossRefGoogle Scholar
  33. 33.
    Achenbach S, Ropers D, Pohle K, et al.: Influence of lipidlowering therapy on the progressions of coronary artery calcification. Circulation 2002, 106:1077–1082.PubMedCrossRefGoogle Scholar
  34. 34.
    Lange LA, Lange EM, Bielak LF, et al.: Autosomal genomewide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol 2002, 22:418–423.PubMedCrossRefGoogle Scholar
  35. 35.
    Valdes AM, Wolfe ML, Tate HC, et al.: Association of traditional risk factors with coronary calcification in persons with a family history of premature coronary heart disease: the study of the inherited risk of coronary atherosclerosis. J Investig Med 2001, 49:353–361.PubMedGoogle Scholar
  36. 36.
    Peyser PA, Bielak LF, Chu JS, et al.: Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 2002, 106:304–308.PubMedCrossRefGoogle Scholar
  37. 37.
    Rossouw JE, Anderson GL, Prentice RL, et al.: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002, 288:321–333.PubMedCrossRefGoogle Scholar
  38. 38.
    Marsh MM, Walker VR, Curtiss LK, et al.: Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 1999, 40:893–900.PubMedGoogle Scholar
  39. 39.
    Rosenfeld ME, Kauser K, Martin-McNulty R, et al.: Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis 2002, 164:251–259.PubMedCrossRefGoogle Scholar
  40. 40.
    Mikkola TS, Clarkson TB: Estrogen replacement therapy, atherosclerosis, and vascular functions. Cardiovasc Res 2002, 53:605–619.PubMedCrossRefGoogle Scholar
  41. 41.
    Akhrass F, Evans AT, Wang Y, et al.: Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2003, in press.Google Scholar
  42. 42.
    Nesto RW: Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 1999, 22:1393–1394.PubMedCrossRefGoogle Scholar
  43. 43.
    Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229–234.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Theodore Mazzone
    • 1
  1. 1.Department of Medicine, Section of Diabetes and Metabolism (MC 797)University of IllinoisChicagoUSA

Personalised recommendations